The board of directors at Aeglea BioTherapeutics has a history of experience in the president role at ABShanafelt Advisory, LLC, as well as director roles at Surface Oncology Inc., Symic Bio, and HemaQuest Therapeutics. They also have a strong educational background, with degrees in Chemistry and Physics from Pacific Lutheran University, and Chemistry from University of California, Berkeley.
View all